The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 18, 2020
Filed:
Dec. 21, 2018
Applicant:
Nogra Pharma Limited, Dublin, IE;
Inventors:
Daan Hommes, Los Angeles, CA (US);
Auke Verhaar, Gouda, NL;
Gijs Van den Brink, Abcoude, NL;
Francesca Viti, Salorino, CH;
Assignee:
Nogra Pharma Limited, Dublin, IE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 239/26 (2006.01); C07D 401/14 (2006.01); H04L 12/26 (2006.01); H04L 12/947 (2013.01); C07D 213/36 (2006.01); C07D 217/22 (2006.01); C07D 239/38 (2006.01); A61K 31/506 (2006.01);
U.S. Cl.
CPC ...
C07D 401/14 (2013.01); A61K 31/506 (2013.01); C07D 213/36 (2013.01); C07D 217/22 (2013.01); C07D 239/26 (2013.01); C07D 239/38 (2013.01); H04L 43/0894 (2013.01); H04L 49/251 (2013.01);
Abstract
The present disclosure is directed in part to heterocycles, and their use in treating medical disorders, such as immune inflammatory disorders such as Crohn's disease, ulcerative colitis, rheumatic disorders, psoriasis, and allergies. The compounds are contemplated to modulate T-Cell responses.